Close

Press Releases

Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria Vaccine

Development of a vaccine to prevent the malaria parasite from entering the human liver is the goal of a new collaboration announced by global leaders in malaria research and vaccine development. The PATH Malaria Vaccine Initiative (MVI), Merck (known...

New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib in lung cancer patients

New data to be presented show that afatinib (BIBW 2992) leads to a significant four-fold extension (4.4 months vs. 1 month for placebo) in progression-free survival, - the time before a tumour starts to grow again- , for lung...

The R and D Leaders Band Together at Discovery Summit 2011 to Uncover Innovative Solutions

The Discovery Summit 2011, presented by marcus evans, will be taking place from 21-23 March 2011 in Cannes, France. Confronted by compound challenges the global pharmaceutical scenario needs to redefine its industry dynamics and diversify its global vision. ...

Phase 2 Interim Data Show High Objective Response Rate for Patients Treated with Elotuzumab plus

Abbott and Bristol-Myers Squibb Company announced interim results from the Phase 2 portion of a Phase 1b/2 open-label study which showed a high objective response rate (ORR) among patients with relapsed multiple myeloma who received elotuzumab plus lenalidomide and...

Next-Generation Cell Sorter from Beckman Coulter Enables Multi-Color Flow Cytometry Studies

MoFlo Astrios next-generation cell sorter from Beckman Coulter, Inc. leverages the stable fluidic design of the original MoFlo and the electronic processing of the MoFlo XDP, while expanding sorting capabilities with an array of laser options.  A range of...

FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults

Allergan, Inc. announced the US FDA Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on...

Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan

Baxter International Inc. and Takeda Pharmaceutical Company Limited announced that the parties have completed a Development, License and Technology Transfer Agreement. Under the terms of the agreement, Takeda and Baxter will expand upon their previously announced collaboration to bring...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »